In the latest trading session, Arch Capital Group (ACGL) closed at $99.17, marking a +1.61% move from the previous day. The stock outperformed the S&P 500, which registered a daily gain of 0.33%. Meanwhile, the Dow experienced a rise of 1.08%, and the technology-dominated Nasdaq saw an increase of 0.08%.
Shares of the property and casualty insurer witnessed a gain of 0.65% over the previous month, beating the performance of the Finance sector with its loss of 3.99%, and underperforming the S&P 500's gain of 1.41%.
Investors will be eagerly watching for the performance of Arch Capital Group in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on October 27, 2026. The company is forecasted to report an EPS of $2.05, showcasing a 25.99% downward movement from the corresponding quarter of the prior year. In the meantime, our current consensus estimate forecasts the revenue to be $4.46 billion, indicating a 5.49% decline compared to the corresponding quarter of the prior year.
ACGL's full-year Zacks Consensus Estimates are calling for earnings of $9.7 per share and revenue of $17.72 billion. These results would represent year-over-year changes of -1.42% and -5.7%, respectively.
It's also important for investors to be aware of any recent modifications to analyst estimates for Arch Capital Group. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 2.68% upward. Arch Capital Group is holding a Zacks Rank of #3 (Hold) right now.
Digging into valuation, Arch Capital Group currently has a Forward P/E ratio of 10.06. This signifies a discount in comparison to the average Forward P/E of 11.15 for its industry.
We can also see that ACGL currently has a PEG ratio of 2.93. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. As of the close of trade yesterday, the Insurance - Property and Casualty industry held an average PEG ratio of 1.88.
The Insurance - Property and Casualty industry is part of the Finance sector. This industry currently has a Zacks Industry Rank of 59, which puts it in the top 24% of all 250+ industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Keep in mind to rely on Zacks.com to watch all these stock-impacting metrics, and more, in the succeeding trading sessions.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This innovative software-as-a-service firm upped its user base +22% year over year. That rate is increasing and margins are expanding as AI efficiencies take effect. Of course, all our elite picks aren't winners, but this one could far surpass earlier Zacks' Stocks Set to Double like D-Wave Quantum, which shot up +680.1%.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Arch Capital Group Ltd. (ACGL): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).